Dottorato in Fisiopatologia Medica

Barutta F, Bellini S, Mastrocola R, Gambino R, Piscitelli F, di Marzo V, Corbetta B, Vemuri K, Macriyannis A, Annaratone L, Bruno G, Gruden G (2018) Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy. Br J Pharmacol. 2018 Sep 5. doi: 10.1111/bph.14495.

Barutta F, Bellini S, Mastrocola R, Bruno G, Gruden G (2018) MicroRNA and Microvascular Complications of Diabetes. Int J Endocrinol. 2018, 1-20.

Barutta F, Bruno G, Mastrocola R, Bellini S, Gruden G (2018) The role of cannabinoid signaling in acute and chronic kidney disease. Kidney Int. 94(2), 252-258.

Barutta F, Mastrocola R, Bellini S, Bruno G, Gruden G (2018) Cannabinoid receptors in diabetic kidney disease. Curr Diab Rep. 18(2), 9.              

Bellini S, Fleming KE, De M, McCauley JP, Petroccione MA, O’Brant LY, Tkachenko A, Kwon S, Jones LA, Scimemi A (2018) Neuronal Glutamate Transporters control Dopaminergic Signaling and Compulsive Behaviors. J Neurosci. 38(4), 937-961.

Bellini S, Barutta F, Mastrocola R, Imperatore L, Bruno G, Gruden G (2017) Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective. Int J Mol Sci. 18(12), E2709.

Tropea D, Mortimer N, Bellini S, Molinos I, Sanfeliu A, Shovlin S, McAllister D, Gill M, Mitchell K, Corvin A (2016). Expression of nuclear Methyl-CpG binding protein 2 (Mecp2) is dependent on neuronal stimulation and application of Insuline-like growth factor 1. Neurosci. Lett. 16, 111-116.

Tropea D, Molinos I, Petit E, Bellini S, Nagakura I, O'Tuathaigh C, Schorova L, Mitchel Kl, Waddington J, Sur M, Gill M and Corvin A (2016). Disrupted in schizophrenia 1 (DISC1) L100P mutants have impaired activity-dependent plasticity in vivo and in vitro. Trans Psychiatry. 6, e712.

Barutta F, Grimaldi S, Franco I, Bellini S, Gambino R, Pinach S, Corbelli A, Bruno G, Rastaldi MP, Aveta T, Hirsch E, Di Marzo V, Gruden G (2014). Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice. Kidney Int. 86, 979-990.

Morris DW, Pearson RD, Cormican P, Kenny EM, O'Dushlaine CT, Perreault LP, Giannoulatou E, Tropea D, Maher BS, Wormley B, Kelleher E, Fahey C, Molinos I, Bellini S, Pirinen M, Strange A, Freeman C, Thiselton DL, Elves RL, Regan R, Ennis S, Dinan TG, McDonald C, Murphy KC, O'Callaghan E, Waddington JL, Walsh D, O'Donovan M, Grozeva D, Craddock N, Stone J, Scolnick E, Purcell S, Sklar P, Coe B, Eichler EE, Ophoff R, Buizer J, Szatkiewicz J, Hultman C, Sullivan P, Gurling H, Mcquillin A, St Clair D, Rees E, Kirov G, Walters J, Blackwood D, Johnstone M, Donohoe G; International Schizophrenia Consortium, SGENE+ Consortium, O'Neill FA; Wellcome Trust Case Control Consortium 2, Kendler KS, Gill M, Riley BP, Spencer CC and Corvin A (2014). An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis. Hum Mol Genet. 23, 3316-3326.

Donohoe G, Walters J, Hargreaves A, Rose EJ, Morris DW, Fahey C, Bellini S, Cummins E, Giegling I, Hartmann AM, Möller HJ, Muglia P, Owen MJ, Gill M, O'Donovan MC, Tropea D, Rujescu D and Corvin A (2013). Neuropsychological effects of the CMSD1 genome-wide associated schizophrenia risk variant rs-0503253. Genes Brain Behav. 12, 203-209.